Explore London's tech ecosystem
BACKED is a European seed-stage venture capital fund based in London that invests $500,000–$5 million in founders building generation-defining frontier technology companies. Founded in 2015, the firm has backed over 100 companies including Thought Machine, CloudNC, FabricNano, Hoxton Farms, and Sky Mavis. BACKED closed its third fund at $100 million in November 2025.
Bethnal Green Ventures (BGV) is Europe's leading early-stage tech for good venture capital fund, backing ambitious founders who use technology to tackle significant social and environmental challenges. Founded in 2012 by Paul Miller and Melanie Hayes, BGV pioneered the 'tech for good' accelerator model, invests from pre-seed through to Series A/B, and was the first UK VC to achieve B Corp certification.
The BioIndustry Association (BIA) is the UK trade association representing the innovative life sciences and biotech industry, with over 600 member companies including start-ups, biotechnology firms, pharmaceutical companies, universities, and research centres. Founded in 1989, it advocates for its members through policy influence, hosts more than 40 networking events annually, and publishes sector insights and reports.
Stablecoin payments infrastructure enabling businesses to send and receive cross-border payments via virtual accounts and stablecoin settlement.
Baird Capital is the direct private investment arm of Robert W. Baird & Co., making venture capital, growth equity, and private equity investments in B2B technology, healthcare, and services companies. The firm operates two complementary platforms — a Global Private Equity strategy and a US Venture Capital strategy — with offices in Chicago, Milwaukee, and London. Baird Capital has over three decades of investment experience and a global network of more than 60 investment and operating professionals.
Barclays Accelerator was a fintech accelerator programme launched in 2014 and operated in partnership with Techstars under the Rise brand, supporting global fintech startups through mentorship, co-working hubs, and introductions to large financial institutions. The programme operated hubs in London and New York and had over 120 alumni before being formally wound down by mid-2025.
Builds a large ethically-sourced biodiversity knowledge graph and AI tools to discover and design novel proteins, enzymes and genomes; its platform contains over 100 times more advanced biological systems than leading public databases used by pharmaceutical researchers.
Global carbon ratings agency providing independent risk-based ratings of carbon credits for the voluntary carbon market.
Ophthalmic gene therapy company developing treatments for inherited and prevalent retinal diseases causing vision loss, including X-linked retinitis pigmentosa and dry age-related macular degeneration; has raised approximately $290 million including a $170 million Series B in 2024.
AI-powered talent platform; uses ML for recruiting, talent management, internal mobility and workforce planning.
Beringea is a transatlantic venture capital firm with over 30 years of growth investing experience, managing more than $900m across a portfolio of more than 60 companies. The firm backs rapidly scaling entrepreneurial companies in the UK and Europe at Series A and Series B, as well as Midwest US companies at Series A and beyond, operating offices in Farmington Hills, Michigan and London.
UK social investment arm of the Big Issue Group, providing impact loans and equity to social enterprises and charities since 2005.
Cloud-based home care management platform for domiciliary care agencies, combining scheduling, care monitoring, auditing and predictive analytics for elderly care.
BlackFin Capital Partners is an independent European private equity firm founded in 2009, focused exclusively on financial services companies across Europe. The firm operates two strategies: asset-light buyouts through its PE funds, and early-stage fintech and insurtech investment through its BlackFin Tech VC strategy. It has offices in Paris, Amsterdam, Brussels, Frankfurt, and London, and manages over €2 billion in assets.
Bowmark Capital is a leading private equity investment firm founded in 1997 and headquartered in London, specialising in growth companies valued at up to £300 million across Data and Insight, Managed IT Services, Software, and Tech-enabled Business Services sectors. The firm has a team of over 50 professionals, manages approximately £2 billion in funds under management, and has completed more than 50 investments since inception.
Europe's largest dedicated EdTech VC, backing founders building learning, work, and skills platforms from Pre-Seed to Series A across Europe.
Bristows is a specialist UK law firm founded in 1837, renowned for its expertise in intellectual property, technology, and life sciences. The firm advises innovative clients across IP litigation, transactions, data protection, corporate, competition, and regulatory matters, with offices in London, Brussels, and Dublin.
London-based venture capital arm of GP Bullhound, backing category-leading technology companies across AI, quantum, fintech, and consumer tech globally.
BusinessLDN (previously known as London First) is a cross-sector business campaign group founded in 1992 to make London the best city in the world in which to do business. The organisation advocates on behalf of London's business community on issues including skills and talent, housing and planning, transport, sustainability, and economic competitiveness. It rebranded from London First to BusinessLDN in July 2022.
The Cell and Gene Therapy Catapult is an independent centre of excellence established in 2012 to advance the growth of the UK cell and gene therapy industry and accelerate the development of Advanced Therapy Medicinal Products (ATMPs). It provides infrastructure, specialist manufacturing support, regulatory strategy, NHS adoption facilitation and skills training across sites in London, Stevenage, Braintree and Edinburgh.
Structure-based drug discovery using proprietary DragonFold 3D deep-learning to predict protein-ligand co-folding for hard targets, initially in oncology.
The Centre for Long-Term Resilience (CLTR) is an independent UK nonprofit think tank focused on transforming global resilience to extreme risks, including extreme AI risks, extreme biological risks, and government risk management capacity. It conducts research and provides policy advice to governments and institutions to improve governance, processes and decision-making around high-impact, globally reaching threats. CLTR was founded in 2019 and is registered under the name Alpenglow Group Limited.
AI-powered regulatory intelligence and compliance automation platform that maps global regulations for banks, asset managers and other regulated institutions.
The Campaign for Science and Engineering (CaSE) is the UK's leading independent advocate for science and engineering, arguing for increased R&D funding and better science policy. It represents over 115 scientific organisations including businesses, universities, professional bodies, and research charities, and was originally founded in 1986 as Save British Science.